Afatinib versus cisplatin plus pemetrexed in Japanese patients with advanced non‐small cell lung cancer harboring activating EGFR mutations: Subgroup analysis of LUX‐Lung 3

Publisher: John Wiley & Sons Inc

E-ISSN: 1349-7006|1347-9032|9|1202-1211

ISSN: 1347-9032

Source: Cancer Science, Vol.1347-9032, Iss.9, 2015-09, pp. : 1202-1211

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract